Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). (Q37827010)

23 August 2017

1 reference

title

Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). (English)

1 reference

23 August 2017

1 reference

1 reference

1 reference

Pamela J Goodwin

2

0 references

author name string

Julie Lemieux

1

1 reference

23 August 2017

Louise J Bordeleau

3

1 reference

23 August 2017

Sophie Lauzier

4

1 reference

23 August 2017

Valérie Théberge

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

7 January 2011

1 reference

Journal of the National Cancer Institute

23 August 2017

1 reference

23 August 2017

103

1 reference

23 August 2017

3

1 reference

23 August 2017

178-231

1 reference

Quality of life end points in cancer clinical trials: review and recommendations

23 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized clinical trial comparing axillary padding with closed suction drainage for the axillary wound after lymphadenectomy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and N

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Clinical interpretation of quality-of-life outcomes: an investigation of data from the randomized trial of gemcitabine plus paclitaxel compared with paclitaxel alone for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Examining quality of life issues in relation to endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Giving patients a choice improves quality of life: a multi-centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy of an in-home nursing intervention following short-stay breast cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Erythropoietin treatment in metastatic breast cancer--effects on Hb, quality of life and need for transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A pilot study of magnetic therapy for hot flashes after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Virtual reality intervention for older women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Transcutaneous electrical nerve stimulation vs. transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Lessons learned: Outcomes and methodology of a coping skills intervention trial comparing individual and group formats for patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of computer support on younger women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A problem-solving approach to stress reduction among younger women with breast carcinoma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of cognitive-existential group therapy on survival in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Psychological adjustment among African American breast cancer patients: one-year follow-up results of a randomized psychoeducational group intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Psychosocial intervention for rural women with breast cancer: The Sierra-Stanford Partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effect of a psychosocial group intervention on loneliness and social support for Japanese women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A psychosocial group intervention for Japanese women with primary breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy of therapeutic group by telephone for women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Short-term effects of telephone therapy for breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Distress reduction from a psychological intervention contributes to improved health for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A pilot randomized trial assessing the effects of autogenic training in early stage cancer patients in relation to psychological status and immune system responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Video preparation for breast cancer treatment planning: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized intervention study for breast cancer survivors in Japan: effects of short-term support group focused on possible breast cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Art therapy improves experienced quality of life among women undergoing treatment for breast cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Responsiveness to change [corrected] due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effect of group psychosocial support on survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Virtual reality as a distraction intervention for women receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Treatment of radiotherapy-induced fatigue through a nonpharmacological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

An individualized representational intervention to improve symptom management (IRIS) in older breast cancer survivors: three pilot studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Depression and anxiety in women with breast cancer and their partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Maintenance of physical activity in breast cancer survivors after a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial of exercise therapy in women treated for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Tai Chi Chuan for breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A brief intervention for fatigue management in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of supervised exercise therapy in patients receiving radiotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A randomized trial to increase physical activity in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Physical activity and health outcomes three months after completing a physical activity behavior change intervention: persistent and delayed effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Restorative yoga for women with breast cancer: findings from a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Total parenteral nutrition vs oral diet in autologous hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life in older women with early-stage breast cancer in the first year of survivorship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Preliminary evaluation of psychoeducational support interventions on quality of life in rural breast cancer survivors after primary treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Individual psychosocial support for breast cancer patients: a randomized study of nurse versus psychologist interventions and standard care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast cancer patients--a randomised study of nurse versus psychologist interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Massage relieves nausea in women with breast cancer who are undergoing chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer -- a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Immune response, depression and fatigue in relation to support intervention in mammary cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

The effectiveness of a psycho-educational group after early-stage breast cancer treatment: results of a randomized French study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Evidence-based treatment and practice: new opportunities to bridge clinical research and practice, enhance the knowledge base, and improve patient care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Patient initiated follow up of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Efficacy of comprehensive group rehabilitation for women with early breast cancer in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

A Randomized Controlled Trial of Relaxation Training to Reduce Hot Flashes in Women with Primary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

Combined Aerobic and Resistance Training in Breast Cancer Survivors: A Randomized, Controlled Pilot Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ508

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJQ508

1 reference

23 August 2017

1 reference